Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vin-Cent Wu

Showing results (1-10 of 463) with videos related to

Pageof 47
Sort By:
Nephrology (Carlton, Vic.)|January 21, 2024
Unravelling the role of urinary liver-type fatty acid binding protein in histone-induced AKILi-Chun Lin, Vin-Cent Wu
Nephrology (Carlton, Vic.)|February 25, 2012
Aliskiren for reninomaChia-Ter Chao, Vin-Cent Wu
Nephrology (Carlton, Vic.)|March 25, 2026
Editorial: The Diagnostic Void in Kidney Care: Addressing Albuminuria Testing Gaps and the Paradox of AgeingYun-Tao Huang, Vin-Cent Wu
Nephrology (Carlton, Vic.)|April 29, 2024
The dynamics and outcomes of AKI progression during the COVID-19 pandemicZheng-Hong Jiang, Vin-Cent Wu
Nephrology (Carlton, Vic.)|November 3, 2025
Long Non-Coding RNA NNT-AS1 Links Inflammation, Tubular Injury, and Prognosis in Septic AKIYu-Ting Chou, Vin-Cent Wu
Nephrology (Carlton, Vic.)|April 23, 2025
Acute Kidney Injury in Hospitalised Cancer Patients: Incidence, Risk Factors, and OutcomesYu-Tang Sung, Vin-Cent Wu
Nephrology (Carlton, Vic.)|September 11, 2024
Hydrogen sulfide as a therapeutic agent in renal ischemia-reperfusion injury: Mechanistic insights and clinical potentialChih-Ning Chen, Vin-Cent Wu
Kidney International|March 16, 2012
KLOTHO methylation is linked to uremic toxins and chronic kidney diseaseGuang-Huar Young, Vin-Cent Wu
Journal of Thoracic Disease|April 3, 2018
Call for screening for primary aldosteronism: an underdiagnosed and treatable diseaseLeay Kiaw Er, Vin-Cent Wu,
European Journal of Endocrinology|February 9, 2023
Surgical versus medical treatment for unilateral primary aldosteronism: an alternative to a randomized controlled trialSheng-Yin Chen, Vin-Cent Wu
Pageof 47

Showing results (1-10 of 463) with videos related to

Sort By:
Pageof 47
Nephrology (Carlton, Vic.)|January 21, 2024
Unravelling the role of urinary liver-type fatty acid binding protein in histone-induced AKILi-Chun Lin, Vin-Cent Wu
Nephrology (Carlton, Vic.)|February 25, 2012
Aliskiren for reninomaChia-Ter Chao, Vin-Cent Wu
Nephrology (Carlton, Vic.)|March 25, 2026
Editorial: The Diagnostic Void in Kidney Care: Addressing Albuminuria Testing Gaps and the Paradox of AgeingYun-Tao Huang, Vin-Cent Wu
Nephrology (Carlton, Vic.)|April 29, 2024
The dynamics and outcomes of AKI progression during the COVID-19 pandemicZheng-Hong Jiang, Vin-Cent Wu
Nephrology (Carlton, Vic.)|November 3, 2025
Long Non-Coding RNA NNT-AS1 Links Inflammation, Tubular Injury, and Prognosis in Septic AKIYu-Ting Chou, Vin-Cent Wu
Nephrology (Carlton, Vic.)|April 23, 2025
Acute Kidney Injury in Hospitalised Cancer Patients: Incidence, Risk Factors, and OutcomesYu-Tang Sung, Vin-Cent Wu
Nephrology (Carlton, Vic.)|September 11, 2024
Hydrogen sulfide as a therapeutic agent in renal ischemia-reperfusion injury: Mechanistic insights and clinical potentialChih-Ning Chen, Vin-Cent Wu
Kidney International|March 16, 2012
KLOTHO methylation is linked to uremic toxins and chronic kidney diseaseGuang-Huar Young, Vin-Cent Wu
Journal of Thoracic Disease|April 3, 2018
Call for screening for primary aldosteronism: an underdiagnosed and treatable diseaseLeay Kiaw Er, Vin-Cent Wu,
European Journal of Endocrinology|February 9, 2023
Surgical versus medical treatment for unilateral primary aldosteronism: an alternative to a randomized controlled trialSheng-Yin Chen, Vin-Cent Wu
Pageof 47